| scholarly article | Q13442814 |
| P50 | author | Riitta Veijola | Q40817090 |
| Mikael Knip | Q47161413 | ||
| P2093 | author name string | Jorma Ilonen | |
| Olli Simell | |||
| Anne Hekkala | |||
| Jyrki Lähde | |||
| Satu Simell | |||
| Tuula Simell | |||
| Paula Vähäsalo | |||
| Heli T A Siljander | |||
| P2860 | cites work | IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. | Q50893232 |
| Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop | Q53392926 | ||
| Simplifying Likelihood Ratios. | Q55514377 | ||
| Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial | Q62587898 | ||
| A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes | Q68564203 | ||
| Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies | Q71150178 | ||
| Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group | Q71617269 | ||
| Triple-label hybridization assay for type-1 diabetes-related HLA alleles | Q71908990 | ||
| Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group | Q72134575 | ||
| Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives | Q72717711 | ||
| Proposed guidelines on screening for risk of type 1 diabetes | Q73526414 | ||
| Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort | Q73795603 | ||
| A novel micro-assay for insulin autoantibodies | Q73893605 | ||
| Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children | Q77619587 | ||
| HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families | Q28190733 | ||
| Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies | Q28237011 | ||
| The rise of childhood type 1 diabetes in the 20th century. | Q30332258 | ||
| Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends | Q31473026 | ||
| Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study | Q36832937 | ||
| Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group | Q37377371 | ||
| Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study | Q40088313 | ||
| Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk | Q40346082 | ||
| Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes | Q41199553 | ||
| Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group | Q43607374 | ||
| Genetic risk determines the emergence of diabetes-associated autoantibodies in young children | Q43901584 | ||
| Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers | Q43938791 | ||
| Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes | Q44732804 | ||
| Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents | Q47407293 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 2835-2842 | |
| P577 | publication date | 2009-09-15 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population | |
| P478 | volume | 58 |
| Q57133051 | A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk |
| Q59133401 | A longitudinal plasma lipidomics dataset from children who developed islet autoimmunity and type 1 diabetes |
| Q30557549 | Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants |
| Q33751495 | Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth |
| Q35043330 | Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young |
| Q36762700 | Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children. |
| Q50950195 | Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies. |
| Q89944637 | Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route |
| Q37213887 | Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets |
| Q53621804 | CD4⁺ T-cell proliferation responses to wheat polypeptide stimulation in children at different stages of type 1 diabetes autoimmunity. |
| Q92833857 | Circulating metabolites in progression to islet autoimmunity and type 1 diabetes |
| Q50120159 | Class II HLA Genotype Association with First Phase Insulin Response Is Explained by Islet Autoantibodies |
| Q47245204 | Clinical and biochemical features at diagnosis of type 1 diabetes in patients between 0 and 18 years of age from Jordan. |
| Q89897923 | Consumption of differently processed milk products in infancy and early childhood and the risk of islet autoimmunity |
| Q37110596 | Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes |
| Q61812173 | Cord-Blood Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes |
| Q35116303 | Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? |
| Q34567034 | Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity |
| Q38837965 | Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects? |
| Q90129589 | Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes - Type 1 Diabetes Prediction and Prevention Study (DIPP) |
| Q37062268 | ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study |
| Q57583443 | Early introduction of root vegetables in infancy associated with advanced ß-cell autoimmunity in young children with human leukocyte antigen-conferred susceptibility to Type 1 diabetes |
| Q48244211 | Early life origin of type 1 diabetes |
| Q62587873 | Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk |
| Q56637648 | Environmental triggers of type 1 diabetes |
| Q35910119 | Etiopathogenesis of insulin autoimmunity |
| Q35227148 | Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. |
| Q47608755 | Exocrine pancreas function decreases during the progression of the beta-cell damaging process in young prediabetic children |
| Q61811655 | FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children |
| Q57924676 | Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis |
| Q42370198 | Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child |
| Q38679602 | Increasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests |
| Q38034937 | Influence of type 1 diabetes genes on disease progression: similarities and differences between countries |
| Q46115645 | Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies |
| Q48786260 | Maternal VDR variants rather than 25-hydroxyvitamin D concentration during early pregnancy are associated with type 1 diabetes in the offspring |
| Q39304710 | Maternal dietary fatty acid intake during pregnancy and the risk of preclinical and clinical type 1 diabetes in the offspring |
| Q89642763 | Metabolic alterations in immune cells associate with progression to type 1 diabetes |
| Q51302837 | OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis. |
| Q37193363 | Patterns of β-cell autoantibody appearance and genetic associations during the first years of life |
| Q52655231 | Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances. |
| Q50066962 | Predicting progression to diabetes in islet autoantibody positive children |
| Q33873033 | Prediction of type 1 diabetes in the general population |
| Q35531906 | Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). |
| Q42407419 | Predictors of slow progression to diabetes in children with multiple islet autoantibodies |
| Q38734604 | Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity |
| Q37022756 | Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity |
| Q36461183 | Reduced β-cell function in early preclinical type 1 diabetes |
| Q38842309 | Role of humoral beta-cell autoimmunity in type 1 diabetes |
| Q64237463 | Serum 25-Hydroxyvitamin D Concentrations at Birth in Children Screened for HLA-DQB1 Conferred Risk for Type 1 Diabetes |
| Q35502154 | Strategies for the prevention of autoimmune type 1 diabetes |
| Q40735953 | The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients |
| Q35976782 | The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1. |
| Q34496850 | The pancreas in human type 1 diabetes |
| Q37106456 | The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients |
| Q91749804 | Type 1 diabetes linked PTPN22 gene polymorphism is associated with the frequency of circulating regulatory T cells |
| Q43731070 | Validation of molecular and genomic biomarkers of retinal drug efficacy: use of ocular fluid sampling to evaluate VEGF. |
Search more.